欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/V/0267/001
药品名称Eurican CHPPi2-LR
活性成分
    • canine adenovirus 4.9 GKID50
    • canine distemper virus 4.7 GKID50
    • canine parainfluenza virus 4.6 GKID50
    • canine parvovirus 4.9 GKID50
    • leptospira interrogans serogroup canicola 32.0 MALR
    • leptospira interrogans serogroup icterohaemorragiae 32.0 MALR
    • rabies virus 2.0 IU
剂型Suspension for injection
上市许可持有人MERIAL
参考成员国 - 产品名称France (FR)
Eurican DAPPI-LR
互认成员国 - 产品名称
    • Germany (DE)
      Eurican DAPPi-LR
    • Spain (ES)
      EURICAN MHPPi2-LR
    • Portugal (PT)
    • Greece (GR)
    • Poland (PL)
      Eurican DHPPi2-LR
    • Cyprus (CY)
许可日期2013/09/25
最近更新日期2024/09/05
药物ATC编码
    • QI07AJ06 live canine distemper virus + live canine adenovirus + live parainfluenza virus + live canine parvovirus + inactivated rabies + inactivated leptospira
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase